L-Arginine: Clinical Trials

8 trials of L-Arginine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 active not recruiting, 1 terminated. 8 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 18Completed 6, Active not recruiting 1, Terminated 1
Phase 21Completed 1

Follow L-Arginine: new trials by email Literature Review of L-Arginine trials Research Report on L-Arginine

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication
Tetrahydrobiopterin 10 mg/kg, Tetrahydrobiopterin 20 mg/kg, L-Ascorbate - Claudication, Intermittent, Peripheral Artery Disease
Phase 1Active not recruitingLouis Messina102021-06-152026-04-15
The Effect of Endothelin and L-Arginine on Racial Differences in Vasoconstriction
BQ-788, BQ-123, L-Arginine - Cardiovascular Diseases, Cardiovascular Risk Factor
Phase 1CompletedThe University of Texas at Arlington192018-10-012024-06-11
Safety, Tolerability and Effects of L-Arginine in Boys With Dystrophinopathy on Corticosteroids
L-arginine - Dystrophinopathy, Duchenne Muscular Dystrophy
Phase 1CompletedMassachusetts General Hospital72012-01-012012-07-03
Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and Metformin
Metformin, L-Arginine - Duchenne Muscular Dystrophy
Phase 1CompletedUniversity Hospital, Basel, Switzerland52012-01-012015-08-07
Prospective L-arginine Study
L-arginine - Heart Transplant
Phase 1TerminatedUniversity of Michigan32011-07-012017-01-10
Supplementation of L-arginine in Patients With Non-resectable Brain Metastases
L-arginine hydrochloride solution, Placebo - Unresectable Multiple Brain Metastases
Phase 1 / Phase 2CompletedInstituto de Oncología Ángel H. Roffo702004-05-012016-07-28
Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell Anemia
Hydroxyurea, L-Arginine, Sildenafil - Sickle Cell Anemia
Phase 1CompletedNational Institutes of Health Clinical Center (CC)392003-03-102019-11-22
Treatment of Supine Hypertension in Autonomic Failure
Clonidine, Nitroglycerin transdermal, Dipyridamole/ Aspirin (Aggrenox) - Hypertension
Phase 1CompletedVanderbilt University1522001-01-012017-10-13

Conditions studied

Muscular Dystrophy, Duchenne (2)  ·  Anemia, Sickle Cell (1)  ·  Cardiovascular Diseases (1)  ·  Hypertension (1)  ·  Intermittent Claudication (1)  ·  Multiple System Atrophy (1)  ·  Neoplasms (1)  ·  Peripheral Arterial Disease (1)  ·  Peripheral Vascular Diseases (1)  ·  Pure Autonomic Failure (1)  ·  Shy-Drager Syndrome (1)

Sponsors

Instituto de Oncología Ángel H. Roffo (1)  ·  Louis Messina (1)  ·  Massachusetts General Hospital (1)  ·  National Institutes of Health Clinical Center (CC) (1)  ·  The University of Texas at Arlington (1)  ·  University Hospital, Basel, Switzerland (1)  ·  University of Michigan (1)  ·  Vanderbilt University (1)

Countries

United States (6)

Top investigators

Alfredo H Navigante, MD, Phd (1)  ·  Dirk Fischer, MD (1)  ·  Italo Biaggioni, MD (1)  ·  John F Tisdale, M.D. (1)  ·  Louis M Messina, MD (1)  ·  Namita Goyal, MD (1)

Results publications

PMID 10851208, PMID 11927799, PMID 12119802, PMID 12923400, PMID 15738343, PMID 16391172, PMID 16533484, PMID 18426998, PMID 19047577, PMID 19738158, PMID 22801444, PMID 23266540, PMID 26799743, PMID 9369256, PMID 9890307